Drug intelligence / Profile preview

ketamine + dexamethasone

Development stage
Unknown
Lead developer
Pfizer
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Intravenous, Perineural
01

Overview

Ketamine + dexamethasone is a combination of two pharmaceutical agents used primarily as adjuvants in anesthesia and pain management. Ketamine is a rapid-acting general anesthetic and NMDA receptor antagonist, while dexamethasone is a potent synthetic corticosteroid with anti-inflammatory and immunosuppressant properties. When administered together, typically intravenously or as additives to local anesthetics (such as lidocaine or bupivacaine), this combination has been shown to prolong the duration of analgesia, reduce postoperative pain scores, and improve mood outcomes after surgery. The mechanism involves ketamine’s blockade of NMDA receptors leading to analgesia and antidepressant effects, while dexamethasone acts via glucocorticoid receptor-mediated inhibition of pro-inflammatory pathways[3][4][6]. This combination has been studied in various surgical settings including gynecologic surgery, pediatric abdominal operations, and regional nerve blocks[1][2][3].

Other names
ketamine + dexamethasoneketamine hydrochloride and dexamethasone sodium phosphate
02

Targets

GR (Glucocorticoid receptor)NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on ketamine + dexamethasone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ketamine + dexamethasone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call